Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1173101

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1173101

Asia Pacific PEGylated Proteins Market Size, Share & Industry Trends Analysis Report By Product & Services, By Type, By End-user, By Application, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 96 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Asia Pacific PEGylated Proteins Market would witness market growth of 12.1% CAGR during the forecast period (2022-2028).

Hemophilia A or B congenital disorders in adults and adolescents can be treated with the recombinant factor VIIa, Sevenfact. As a result, it is projected that regulatory backing and several product approvals for biologics will accelerate the industry's expansion. The funding for research and development of therapeutic proteins has expanded due to the ongoing regulatory support shown by the approvals of biological products.

Major pharmaceutical companies are refocusing their research and development budgets on biologics in an effort to develop fresh and efficient methods, tools, or drug delivery formulations. PEGylated proteins, a type of therapeutic, offer novel benefits such as improved half-life and drug stability in circulation. PEGylated substances are also non-toxic, water-soluble or hydrophilic, non-antigenic, and non-immunogenic, and the US FDA has so generally acknowledged them as safe.

These characteristics allow PEGylated proteins to remain in the body for a relatively long period of time, which finally results in a reduction in the frequency of dose and an increase in patient adherence to the therapy. The effective use of PEG molecules in biopharmaceuticals and the benefits that come with it have intensified research efforts for PEGylation technology and are anticipated to boost the market during the projected period.

The trend of gastrointestinal disease in the Asia-Pacific area has seen noticeable changes since the turn of the millennium. Since the region is home to over half of the world's population, these changes have a big impact on the burden of disease worldwide. Asia has been reported to have the greatest incidence of gastric cancer (GCA), which is still a very serious cancer. However, time-trend studies have revealed a decline in the incidence of GCA in some Asian nations.

The China market dominated the Asia Pacific PEGylated Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $171.3 million by 2028.The Japan market is estimated to grow a CAGR of 11.4% during (2022 - 2028). Additionally, The India market would display a CAGR of 12.8% during (2022 - 2028).

Based on Product & Services, the market is segmented into Consumables and Services. Based on Type, the market is segmented into Colony-stimulating Factor, Interferons, Recombinant Factor VII, Erythropoietin and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic & Research Institutes. Based on Application, the market is segmented into Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Millipore (Merck KGaA), Thermo Fisher Scientific, Inc., NOF Corporation, JenKem Technology Co. Ltd., Creative PEGworks, Celares GmbH, Quanta BioDesign, Ltd., Biomatrik, Inc., Iris Biotech GmbH, and Laysan Bio, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product & Services

  • Consumables
  • Services

By Type

  • Colony-stimulating Factor
  • Interferons
  • Recombinant Factor VII
  • Erythropoietin
  • Others

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes

By Application

  • Cancer
  • Autoimmune Diseases
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Gastrointestinal Disorders
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Merck Millipore (Merck KGaA)
  • Thermo Fisher Scientific, Inc.
  • NOF Corporation
  • JenKem Technology Co. Ltd.
  • Creative PEGworks
  • Celares GmbH
  • Quanta BioDesign, Ltd.
  • Biomatrik, Inc.
  • Iris Biotech GmbH
  • Laysan Bio, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific PEGylated Proteins Market, by Product & Services
    • 1.4.2 Asia Pacific PEGylated Proteins Market, by Type
    • 1.4.3 Asia Pacific PEGylated Proteins Market, by End-user
    • 1.4.4 Asia Pacific PEGylated Proteins Market, by Application
    • 1.4.5 Asia Pacific PEGylated Proteins Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in PEGylated Proteins Market

Chapter 4. Asia Pacific PEGylated Proteins Market by Product & Services

  • 4.1 Asia Pacific Consumables Market by Country
  • 4.2 Asia Pacific Services Market by Country

Chapter 5. Asia Pacific PEGylated Proteins Market by Type

  • 5.1 Asia Pacific Colony-stimulating Factor Market by Country
  • 5.2 Asia Pacific Interferons Market by Country
  • 5.3 Asia Pacific Recombinant Factor VII Market by Country
  • 5.4 Asia Pacific Erythropoietin Market by Country
  • 5.5 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific PEGylated Proteins Market by End-user

  • 6.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
  • 6.2 Asia Pacific Contract Research Organizations (CROs) Market by Country
  • 6.3 Asia Pacific Academic & Research Institutes Market by Country

Chapter 7. Asia Pacific PEGylated Proteins Market by Application

  • 7.1 Asia Pacific Cancer Market by Country
  • 7.2 Asia Pacific Autoimmune Diseases Market by Country
  • 7.3 Asia Pacific Hepatitis Market by Country
  • 7.4 Asia Pacific Multiple Sclerosis Market by Country
  • 7.5 Asia Pacific Hemophilia Market by Country
  • 7.6 Asia Pacific Gastrointestinal Disorders Market by Country
  • 7.7 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific PEGylated Proteins Market by Country

  • 8.1 China PEGylated Proteins Market
    • 8.1.1 China PEGylated Proteins Market by Product & Services
    • 8.1.2 China PEGylated Proteins Market by Type
    • 8.1.3 China PEGylated Proteins Market by End-user
    • 8.1.4 China PEGylated Proteins Market by Application
  • 8.2 Japan PEGylated Proteins Market
    • 8.2.1 Japan PEGylated Proteins Market by Product & Services
    • 8.2.2 Japan PEGylated Proteins Market by Type
    • 8.2.3 Japan PEGylated Proteins Market by End-user
    • 8.2.4 Japan PEGylated Proteins Market by Application
  • 8.3 India PEGylated Proteins Market
    • 8.3.1 India PEGylated Proteins Market by Product & Services
    • 8.3.2 India PEGylated Proteins Market by Type
    • 8.3.3 India PEGylated Proteins Market by End-user
    • 8.3.4 India PEGylated Proteins Market by Application
  • 8.4 South Korea PEGylated Proteins Market
    • 8.4.1 South Korea PEGylated Proteins Market by Product & Services
    • 8.4.2 South Korea PEGylated Proteins Market by Type
    • 8.4.3 South Korea PEGylated Proteins Market by End-user
    • 8.4.4 South Korea PEGylated Proteins Market by Application
  • 8.5 Singapore PEGylated Proteins Market
    • 8.5.1 Singapore PEGylated Proteins Market by Product & Services
    • 8.5.2 Singapore PEGylated Proteins Market by Type
    • 8.5.3 Singapore PEGylated Proteins Market by End-user
    • 8.5.4 Singapore PEGylated Proteins Market by Application
  • 8.6 Malaysia PEGylated Proteins Market
    • 8.6.1 Malaysia PEGylated Proteins Market by Product & Services
    • 8.6.2 Malaysia PEGylated Proteins Market by Type
    • 8.6.3 Malaysia PEGylated Proteins Market by End-user
    • 8.6.4 Malaysia PEGylated Proteins Market by Application
  • 8.7 Rest of Asia Pacific PEGylated Proteins Market
    • 8.7.1 Rest of Asia Pacific PEGylated Proteins Market by Product & Services
    • 8.7.2 Rest of Asia Pacific PEGylated Proteins Market by Type
    • 8.7.3 Rest of Asia Pacific PEGylated Proteins Market by End-user
    • 8.7.4 Rest of Asia Pacific PEGylated Proteins Market by Application

Chapter 9. Company Profiles

  • 9.1 Thermo Fisher Scientific, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Product Launches and Product Expansions:
      • 9.1.5.3 Acquisition and Mergers:
  • 9.2 Merck Millipore ( Merck Group)
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
  • 9.3 NOF Corporation
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expenses
  • 9.4 Beijing Jiankai Technology Co., Ltd. (Jenkem)
    • 9.4.1 Company Overview
  • 9.5 Creative PEGworks
    • 9.5.1 Company Overview
  • 9.6 Celares GmbH
    • 9.6.1 Company Overview
  • 9.7 Quanta BioDesign Ltd.
    • 9.7.1 Company Overview
  • 9.8 Biomatrik, Inc.
    • 9.8.1 Company Overview
  • 9.9 Iris Biotech GmbH
    • 9.9.1 Company Overview
  • 9.10. Laysan Bio, Inc.
    • 9.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Asia Pacific PEGylated Proteins Market, 2018 - 2021, USD Million
  • TABLE 2 Asia Pacific PEGylated Proteins Market, 2022 - 2028, USD Million
  • TABLE 3 Asia Pacific PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
  • TABLE 4 Asia Pacific PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
  • TABLE 5 Asia Pacific Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 6 Asia Pacific Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 7 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
  • TABLE 8 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
  • TABLE 9 Asia Pacific PEGylated Proteins Market by Type, 2018 - 2021, USD Million
  • TABLE 10 Asia Pacific PEGylated Proteins Market by Type, 2022 - 2028, USD Million
  • TABLE 11 Asia Pacific Colony-stimulating Factor Market by Country, 2018 - 2021, USD Million
  • TABLE 12 Asia Pacific Colony-stimulating Factor Market by Country, 2022 - 2028, USD Million
  • TABLE 13 Asia Pacific Interferons Market by Country, 2018 - 2021, USD Million
  • TABLE 14 Asia Pacific Interferons Market by Country, 2022 - 2028, USD Million
  • TABLE 15 Asia Pacific Recombinant Factor VII Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Asia Pacific Recombinant Factor VII Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Asia Pacific Erythropoietin Market by Country, 2018 - 2021, USD Million
  • TABLE 18 Asia Pacific Erythropoietin Market by Country, 2022 - 2028, USD Million
  • TABLE 19 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 20 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 21 Asia Pacific PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
  • TABLE 22 Asia Pacific PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
  • TABLE 23 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 24 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 25 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
  • TABLE 26 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
  • TABLE 27 Asia Pacific Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 28 Asia Pacific Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 29 Asia Pacific PEGylated Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 30 Asia Pacific PEGylated Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 31 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 32 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 33 Asia Pacific Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 34 Asia Pacific Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 35 Asia Pacific Hepatitis Market by Country, 2018 - 2021, USD Million
  • TABLE 36 Asia Pacific Hepatitis Market by Country, 2022 - 2028, USD Million
  • TABLE 37 Asia Pacific Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
  • TABLE 38 Asia Pacific Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
  • TABLE 39 Asia Pacific Hemophilia Market by Country, 2018 - 2021, USD Million
  • TABLE 40 Asia Pacific Hemophilia Market by Country, 2022 - 2028, USD Million
  • TABLE 41 Asia Pacific Gastrointestinal Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 42 Asia Pacific Gastrointestinal Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 43 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 44 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 45 Asia Pacific PEGylated Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 46 Asia Pacific PEGylated Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 47 China PEGylated Proteins Market, 2018 - 2021, USD Million
  • TABLE 48 China PEGylated Proteins Market, 2022 - 2028, USD Million
  • TABLE 49 China PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
  • TABLE 50 China PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
  • TABLE 51 China PEGylated Proteins Market by Type, 2018 - 2021, USD Million
  • TABLE 52 China PEGylated Proteins Market by Type, 2022 - 2028, USD Million
  • TABLE 53 China PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
  • TABLE 54 China PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
  • TABLE 55 China PEGylated Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 56 China PEGylated Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 57 Japan PEGylated Proteins Market, 2018 - 2021, USD Million
  • TABLE 58 Japan PEGylated Proteins Market, 2022 - 2028, USD Million
  • TABLE 59 Japan PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
  • TABLE 60 Japan PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
  • TABLE 61 Japan PEGylated Proteins Market by Type, 2018 - 2021, USD Million
  • TABLE 62 Japan PEGylated Proteins Market by Type, 2022 - 2028, USD Million
  • TABLE 63 Japan PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
  • TABLE 64 Japan PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
  • TABLE 65 Japan PEGylated Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 66 Japan PEGylated Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 67 India PEGylated Proteins Market, 2018 - 2021, USD Million
  • TABLE 68 India PEGylated Proteins Market, 2022 - 2028, USD Million
  • TABLE 69 India PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
  • TABLE 70 India PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
  • TABLE 71 India PEGylated Proteins Market by Type, 2018 - 2021, USD Million
  • TABLE 72 India PEGylated Proteins Market by Type, 2022 - 2028, USD Million
  • TABLE 73 India PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
  • TABLE 74 India PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
  • TABLE 75 India PEGylated Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 76 India PEGylated Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 77 South Korea PEGylated Proteins Market, 2018 - 2021, USD Million
  • TABLE 78 South Korea PEGylated Proteins Market, 2022 - 2028, USD Million
  • TABLE 79 South Korea PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
  • TABLE 80 South Korea PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
  • TABLE 81 South Korea PEGylated Proteins Market by Type, 2018 - 2021, USD Million
  • TABLE 82 South Korea PEGylated Proteins Market by Type, 2022 - 2028, USD Million
  • TABLE 83 South Korea PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
  • TABLE 84 South Korea PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
  • TABLE 85 South Korea PEGylated Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 86 South Korea PEGylated Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 87 Singapore PEGylated Proteins Market, 2018 - 2021, USD Million
  • TABLE 88 Singapore PEGylated Proteins Market, 2022 - 2028, USD Million
  • TABLE 89 Singapore PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
  • TABLE 90 Singapore PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
  • TABLE 91 Singapore PEGylated Proteins Market by Type, 2018 - 2021, USD Million
  • TABLE 92 Singapore PEGylated Proteins Market by Type, 2022 - 2028, USD Million
  • TABLE 93 Singapore PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
  • TABLE 94 Singapore PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
  • TABLE 95 Singapore PEGylated Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 96 Singapore PEGylated Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 97 Malaysia PEGylated Proteins Market, 2018 - 2021, USD Million
  • TABLE 98 Malaysia PEGylated Proteins Market, 2022 - 2028, USD Million
  • TABLE 99 Malaysia PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
  • TABLE 100 Malaysia PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
  • TABLE 101 Malaysia PEGylated Proteins Market by Type, 2018 - 2021, USD Million
  • TABLE 102 Malaysia PEGylated Proteins Market by Type, 2022 - 2028, USD Million
  • TABLE 103 Malaysia PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
  • TABLE 104 Malaysia PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
  • TABLE 105 Malaysia PEGylated Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 106 Malaysia PEGylated Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 107 Rest of Asia Pacific PEGylated Proteins Market, 2018 - 2021, USD Million
  • TABLE 108 Rest of Asia Pacific PEGylated Proteins Market, 2022 - 2028, USD Million
  • TABLE 109 Rest of Asia Pacific PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
  • TABLE 110 Rest of Asia Pacific PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
  • TABLE 111 Rest of Asia Pacific PEGylated Proteins Market by Type, 2018 - 2021, USD Million
  • TABLE 112 Rest of Asia Pacific PEGylated Proteins Market by Type, 2022 - 2028, USD Million
  • TABLE 113 Rest of Asia Pacific PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
  • TABLE 114 Rest of Asia Pacific PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
  • TABLE 115 Rest of Asia Pacific PEGylated Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 116 Rest of Asia Pacific PEGylated Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 117 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 118 Key Information - Merck Millipore
  • TABLE 119 Key Information - nof corporation
  • TABLE 120 Key Information - Beijing Jiankai Technology Co., Ltd.
  • TABLE 121 Key Information - Creative PEGworks
  • TABLE 122 Key Information - Celares gmbh
  • TABLE 123 Key Information -Quanta biodesign ltd.
  • TABLE 124 Key Information - biomatrik, inc.
  • TABLE 125 Key Information - Iris biotech gmbh
  • TABLE 126 Key Information - laysan bio, inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Thermo Fisher Scientific, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!